These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 15908048

  • 21. Activation in the premotor cortex during mental calculation in patients with Alzheimer's disease: relevance of reduction in posterior cingulate metabolism.
    Ouchi Y, Yoshikawa E, Futatsubashi M, Okada H, Torizuka T, Kaneko M.
    Neuroimage; 2004 May; 22(1):155-63. PubMed ID: 15110005
    [Abstract] [Full Text] [Related]

  • 22. Metabolic correlates of executive dysfunction. Different patterns in mild and very mild Alzheimer's disease.
    Bracco L, Bessi V, Piccini C, Mosconi L, Pupi A, Sorbi S.
    J Neurol; 2007 Aug; 254(8):1052-65. PubMed ID: 17385079
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Impaired cerebral glucose metabolism in prodromal Alzheimer's disease differs by regional intensity normalization.
    Küntzelmann A, Guenther T, Haberkorn U, Essig M, Giesel F, Henze R, Schroeter ML, Schröder J, Schönknecht P.
    Neurosci Lett; 2013 Feb 08; 534():12-7. PubMed ID: 23182881
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Decreased cortical glucose metabolism in converters from CDR 0.5 to Alzheimer's disease in a community: the Osaki-Tajiri Project.
    Ishii H, Ishikawa H, Meguro K, Tashiro M, Yamaguchi S.
    Int Psychogeriatr; 2009 Feb 08; 21(1):148-56. PubMed ID: 19040787
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. CSF total and phosphorylated tau protein, regional glucose metabolism and dementia severity in Alzheimer's disease.
    Haense C, Buerger K, Kalbe E, Drzezga A, Teipel SJ, Markiewicz P, Herholz K, Heiss WD, Hampel H.
    Eur J Neurol; 2008 Nov 08; 15(11):1155-62. PubMed ID: 18803648
    [Abstract] [Full Text] [Related]

  • 31. Validating the DemTect with 18-fluoro-2-deoxy-glucose positron emission tomography as a sensitive neuropsychological screening test for early alzheimer disease in patients of a memory clinic.
    Scheurich A, Muller MJ, Siessmeier T, Bartenstein P, Schmidt LG, Fellgiebel A.
    Dement Geriatr Cogn Disord; 2005 Nov 08; 20(5):271-7. PubMed ID: 16158009
    [Abstract] [Full Text] [Related]

  • 32. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.
    Engler H, Forsberg A, Almkvist O, Blomquist G, Larsson E, Savitcheva I, Wall A, Ringheim A, Långström B, Nordberg A.
    Brain; 2006 Nov 08; 129(Pt 11):2856-66. PubMed ID: 16854944
    [Abstract] [Full Text] [Related]

  • 33. Association between cognitive performance and cortical glucose metabolism in patients with mild Alzheimer's disease.
    Bokde AL, Teipel SJ, Drzezga A, Thissen J, Bartenstein P, Dong W, Leinsinger G, Born C, Schwaiger M, Moeller HJ, Hampel H.
    Dement Geriatr Cogn Disord; 2005 Nov 08; 20(6):352-7. PubMed ID: 16192725
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Brain metabolic correlates of cerebrospinal fluid beta-amyloid 42 and tau in Alzheimer's disease.
    Vukovich R, Perneczky R, Drzezga A, Förstl H, Kurz A, Riemenschneider M.
    Dement Geriatr Cogn Disord; 2009 Nov 08; 27(5):474-80. PubMed ID: 19439965
    [Abstract] [Full Text] [Related]

  • 37. Neuronal substrates for semantic memory: a positron emission tomography study in Alzheimer's disease.
    Hirono N, Mori E, Ishii K, Imamura T, Tanimukai S, Kazui H, Hashimoto M, Takatsuki Y, Kitagaki H, Sasaki M.
    Dement Geriatr Cogn Disord; 2001 Nov 08; 12(1):15-21. PubMed ID: 11125237
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Neural correlates of cognitive dysfunction in Lewy body diseases and tauopathies: combined assessment with FDG-PET and the CERAD test battery.
    Hellwig S, Frings L, Bormann T, Kreft A, Amtage F, Spehl TS, Weiller C, Tüscher O, Meyer PT.
    Brain Lang; 2013 Nov 08; 127(2):307-14. PubMed ID: 24183466
    [Abstract] [Full Text] [Related]

  • 40. Asymmetries of amyloid-β burden and neuronal dysfunction are positively correlated in Alzheimer's disease.
    Frings L, Hellwig S, Spehl TS, Bormann T, Buchert R, Vach W, Minkova L, Heimbach B, Klöppel S, Meyer PT.
    Brain; 2015 Oct 08; 138(Pt 10):3089-99. PubMed ID: 26280595
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.